Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-020782

Chief Corp. Affairs Officer sold 18,000 shares at $17.72 ($319,010)

  • Chief Corp. Affairs Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jones Aranthan II · Chief Corp. Affairs Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-15 Exercise or conversion : show line 1 in the form +15,000 $11.32 $169,800 111,935 D
2021-03-15 Sale : show line 2 in the form −18,000 $17.72 $319,010 93,935 D
Open-market sales · 18,000 sh · avg $17.72 · $319,010

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-15 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −15,000 55,000 D
Loading xslF345X03/doc4.xml…